These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2640484)

  • 1. [Asymmetric IgG antibodies. Structural, immunochemical and biological studies].
    Margni RA
    Medicina (B Aires); 1989; 49(2):147-54. PubMed ID: 2640484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of asymmetric non-precipitating antibody: presence of a carbohydrate residue in only one Fab region of the molecule.
    Labeta MO; Margni RA; Leoni J; Binaghi RA
    Immunology; 1986 Feb; 57(2):311-7. PubMed ID: 3081439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes.
    Cosio FG; Birmingham DJ; Sexton DJ; Hebert LA
    J Immunol; 1987 Apr; 138(8):2587-92. PubMed ID: 3559208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incomplete anti-Rh antibody agglutination mechanism of trypsinized ORh+ red cells.
    Margni RA; Leoni J; Bazzurro M
    Immunology; 1977 Aug; 33(2):153-60. PubMed ID: 415968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A progesterone-induced protein increases the synthesis of asymmetric antibodies.
    Kelemen K; Bognar I; Paal M; Szekeres-Bartho J
    Cell Immunol; 1996 Jan; 167(1):129-34. PubMed ID: 8548836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of purified precipitating and non-precipitating (coprecipitating) antibodies with hapten and with haptenated protein. Evidence of an asymmetric antibody molecule.
    Ronco JR; Sciutto E; Leoni J; Margni RA; Binaghi RA
    Immunology; 1984 Jul; 52(3):449-56. PubMed ID: 6745995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
    Kawamura H; Berzofsky JA
    J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From IgG monoclonals to IgM-like molecules.
    Ernst M; Meier D; Sonneborn HH
    Hum Antibodies; 1999; 9(3):165-70. PubMed ID: 10690630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential macrophage modulation of asymmetric IgG antibody synthesis by soluble or particulate stimuli.
    Apicella C; Custidiano A; Miranda S; Novoa L; Dokmetjian J; Gentile T
    Immunol Lett; 2006 Mar; 103(2):177-85. PubMed ID: 16376434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixation of the first component of complement (C'la) by human antibodies.
    Rosse WF
    J Clin Invest; 1969 Nov; 47(11):2430-45. PubMed ID: 4180276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).
    Hazenbos WL; Heijnen IA; Meyer D; Hofhuis FM; Renardel de Lavalette CR; Schmidt RE; Capel PJ; van de Winkel JG; Gessner JE; van den Berg TK; Verbeek JS
    J Immunol; 1998 Sep; 161(6):3026-32. PubMed ID: 9743367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric antibodies (AAb) in the female reproductive tract.
    Blois S; Zenclussen AC; Roux ME; Olmos S; di Conza J; Arck PC; Margni RA
    J Reprod Immunol; 2004 Dec; 64(1-2):31-43. PubMed ID: 15596225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiological behaviour of rabbit precipitating and non-precipitating (co-precipitating) antibodies.
    Margni RA; Perdigón G; Abatángelo C; Gentile T; Binaghi RA
    Immunology; 1980 Nov; 41(3):681-6. PubMed ID: 7461708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immune responses in cattle and sheep inoculated with Sarcocystis.
    Gasbarre LC; Suter P; Fayer R
    Am J Vet Res; 1984 Aug; 45(8):1592-6. PubMed ID: 6433756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.
    Kurlander RJ
    J Immunol; 1983 Jul; 131(1):140-7. PubMed ID: 6223069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human IgG Fc receptors.
    Vaughn M; Taylor M; Mohanakumar T
    J Immunol; 1985 Dec; 135(6):4059-65. PubMed ID: 2933458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.